146 related articles for article (PubMed ID: 25110224)
21. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
22. LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention.
Chen X; Rong C; Qi P; Bai W; Yao W; Zhang Y; Dang Y
Int J Gen Med; 2021; 14():1357-1365. PubMed ID: 33889016
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.
Nageh T; Sherwood RA; Harris BM; Thomas MR
Heart; 2005 Sep; 91(9):1181-5. PubMed ID: 16103554
[TBL] [Abstract][Full Text] [Related]
24. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
Deng Q; Hou J; Deng X; Zhong Z
Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
[TBL] [Abstract][Full Text] [Related]
25. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
26. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
[TBL] [Abstract][Full Text] [Related]
27. [Low-density lipoprotein cholesterol target goal attainment rate and related factors in patients with acute coronary syndrome after percutaneous coronary intervention].
Zhang B; Dong X; Zhang Y; Huang R; Yin D; Zheng Z; Liu Y; Zhu H; Zhou X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):290-4. PubMed ID: 24924454
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
29. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
[TBL] [Abstract][Full Text] [Related]
31. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.
Selvanayagam JB; Porto I; Channon K; Petersen SE; Francis JM; Neubauer S; Banning AP
Circulation; 2005 Mar; 111(8):1027-32. PubMed ID: 15723982
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
33. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
34. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
[TBL] [Abstract][Full Text] [Related]
35. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery.
Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Marggraf G; Piotrowski J; Jakob H
Eur J Cardiothorac Surg; 2005 May; 27(5):861-9. PubMed ID: 15848327
[TBL] [Abstract][Full Text] [Related]
37. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
[TBL] [Abstract][Full Text] [Related]
38. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up.
Wang Q; Liang D; Wang F; Li W; Han Y; Zhang W; Xie Y; Xin W; Zhou B; Sun D; Cao F; Xiong L
Int J Cardiol; 2015 Sep; 194():28-35. PubMed ID: 26011261
[TBL] [Abstract][Full Text] [Related]
40. Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.
Madani M; Alizadeh K; Ghazaee SP; Zavarehee A; Abdi S; Shakerian F; Salehi N; Firouzi A
Tex Heart Inst J; 2013; 40(4):410-7. PubMed ID: 24082370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
